SPY313.78-3.27 -1.03%
DIA259.04-3.96 -1.51%
IXIC10,343.89-89.76 -0.86%

Piper Sandler Initiates Coverage On Leap Therapeutics with Overweight Rating, Announces Price Target of $6

Piper Sandler analyst Tyler Van Buren initiates coverage on Leap Therapeutics (NASDAQ:LPTX) with a Overweight rating and announces Price Target of $6.

Benzinga · -
Piper Sandler analyst Tyler Van Buren initiates coverage on Leap Therapeutics (NASDAQ: LPTX) with a Overweight rating and announces Price Target of $6.